For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
220.1 ZAR | -2.16% |
|
-4.02% | +8.17% |
03-08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
03-05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
JOHANNESBURG (Reuters) - South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales.
For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
220.1 ZAR | -2.16% | -4.02% | 5.36B | ||
146 USD | +0.28% | -0.80% | 351B | ||
1st Jan change | Capi. | |
---|---|---|
+8.17% | 5.36B | |
+20.76% | 43.54B | |
+18.62% | 21.51B | |
+17.78% | 15.34B | |
+26.36% | 15.12B | |
+56.55% | 13.37B | |
-0.05% | 6.79B | |
-14.94% | 6.38B | |
-8.87% | 5.73B | |
+27.27% | 4.63B |